Aethlon Medical’s (AEMD) Buy Rating Reiterated at HC Wainwright

HC Wainwright restated their buy rating on shares of Aethlon Medical (NASDAQ:AEMD) in a research report released on Friday,Benzinga reports. HC Wainwright currently has a $7.00 price target on the medical equipment provider’s stock.

Separately, StockNews.com initiated coverage on shares of Aethlon Medical in a report on Friday, November 8th. They set a “sell” rating on the stock.

Aethlon Medical Trading Up 0.2 %

Shares of AEMD stock opened at $0.40 on Friday. Aethlon Medical has a twelve month low of $0.24 and a twelve month high of $2.35. The stock has a fifty day simple moving average of $0.40 and a two-hundred day simple moving average of $0.48.

About Aethlon Medical

Aethlon Medical, Inc, a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation.